Trulieve Cannabis Corp.

Trulieve Cannabis Corp.

TRLV
Trulieve Cannabis Corp.US flagNew York Stock Exchange
10.35
USD
-1.20
- -
1.76BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
1.01
2.29
4.59
6.69
6.48
5.98
6.24
6.17
6.11
Basic EPS, GAAP
-0.04
0.01
- -
- -
0.11
0.48
0.55
0.13
-1.31
-2.79
-0.82
-0.61
-0.42
Free Cash Flow per Basic Share
-0.02
-0.02
- -
- -
-0.19
-0.5
-0.37
-2.04
-0.88
0.8
0.65
1.11
1.24
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.08
-0.06
- -
- -
0.87
0.51
1.05
0.99
-0.61
-3.39
-4.19
-4.77
-4.75
Tangible Book Value per Share
-0.07
-0.05
- -
- -
0.93
0.9
2.54
1.89
0.81
0.04
-0.5
-0.73
-0.6
Basic Weighted Avg Shares
4
4
110
110
102
110
114
139
188
189
190
191
192
Sales/Revenue/Turnover
- -
- -
- -
- -
103
253
522
932
1,218
1,129
1,186
1,181
1,170
Operating Margin (%)
-16,912.65
-23,717.76
- -
- -
34.13
44.83
41.87
22.47
10.32
8.2
7.8
12.56
12.7
Depreciation Expense
- -
- -
- -
- -
3
16
30
78
186
171
166
173
174
Net Income, GAAP
- -
- -
- -
- -
11
53
63
18
-246
-527
-155
-116
-81
Effective Tax Rate (%)
- -
- -
- -
- -
67.03
48.79
59.99
82.68
- -
- -
462.59
227.51
184.2
Profit Margin (%)
-14,768.75
10,162.02
- -
- -
10.59
21
12.08
1.93
-20.2
-46.65
-13.07
-9.85
-6.93
Working Capital
- -
- -
- -
- -
46
113
185
355
383
362
466
436
529
LT Debt
- -
- -
- -
- -
13
77
266
832
943
770
797
533
598
Total Equity
- -
- -
- -
- -
104
133
448
2,147
1,928
1,409
1,249
1,143
1,149
Return on Invested Capital (%)
- -
- -
- -
- -
16.52
31.72
18.07
1.92
- -
- -
-15.64
-9.97
-6.55
Return on Capital (%)
- -
-9.61
- -
- -
21.2
46.05
25.93
3.37
- -
- -
-461.63
109.3
79.94
Return on Common Equity (%)
- -
- -
- -
- -
- -
73.09
71.43
14.01
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
29
30
31
LT Borrowings
474
228
286
LT Finance Leases
310
306
312
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
191
192
192
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
756
563
653
Cash, Cash Equivalents & STI
449
256
353
Accounts Receivable, Net
10
10
14
Inventories
243
242
242
Total Current Liabilities
124
127
124
Payables & Accruals
81
61
79
ST Debt
29
30
31
Deferred Revenue
9
10
10

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3,675.45%
64.49%
-8.49%
Free Cash Flow
9,280.9%
78.46%
71.47%
Net Income, GAAP
-3,090.75%
-303.48%
-24.97%
Sales/Revenue/Turnover
- -
21.34%
-0.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
298
303
284
301
1,186
2025
298
302
288
293
1,181
2026
287
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.12
-0.06
-0.32
-0.31
-0.82
2025
-0.17
-0.07
-0.14
-0.22
-0.61
2026
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Kimberly A. Rivers
Full Time Employees
5,000
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3494 Martin Hurst Road Tallahassee FL United States of America 32351
IPO Date
Sep 25, 2018
Business
Trulieve Cannabis Corp. engages in vertically integrated cannabis operations across the United States, focusing on cultivation, processing, distribution, and retail sales of medical and adult-use cannabis products. The company manufactures and distributes a wide range of cannabis花 products, including flower, concentrates, edibles, tinctures, topicals, and related ancillary products through company-owned dispensaries and, in some states, delivery channels, under multiple brand lines. Main products and services: - Cultivation and production: indoor and greenhouse cultivation; extraction and manufacturing of cannabis concentrates and oil-based products; cryo-freeze and other advanced processing methods; development of pre-rolls and finished consumer goods. - Retail and distribution: branded dispensaries offering direct-to-consumer sales of cannabis and derivative products; in-state medical and adult-use retail operations; managed delivery services where permitted; wholesale supply of products to partner retailers in select markets. - Product categories and brands: cannabis flower; concentrates (cannabis oils, distillates, and extracts); edibles (gummies, chocolates, baked goods); topicals (creams and balms); beverages and other derivative formats; consumer packaging and accessories; proprietary and partner brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One. - Ancillary services: quality control laboratories, post-harvest processing, packaging and labeling compliance, product development and R&D for new formats and dosage forms, and compliance support for regulated markets. Latest major company changes: - Strategic expansion in key markets through acquisitions and integrations of dispensaries or cultivation facilities to broaden geographic footprint and increase retail density; these moves include consolidations and divestitures of ancillary facilities as part of portfolio optimization. - Regulatory and market expansion efforts, including pursuing state-by-state growth with enhanced vertical integration capabilities, enabling more control over supply chains and product quality. - Product and branding updates across platforms, including new product launches and expansions of existing brand lines to address evolving consumer preferences and regulatory changes. - Corporate restructurings and leadership announcements aligned with growth strategies and capital efficiency goals, including realignment of operating segments to reflect state-level operations rather than traditional multi-segment reporting. Industry context and target markets: - Industry: cannabis, with operations spanning cultivation, processing, distribution, and retail within regulated U.S. markets. - Segments: medical cannabis, adult-use recreational cannabis, and derivative product trends such as concentrates, edibles, and topicals. - Customer base: registered medical cannabis patients and adult-use consumers in states where the company operates, with a growing emphasis on brand-based consumer shopping experiences at company-owned locations and compliance-backed delivery where available. - Geographic footprint: United States, with a focus on states permitting medical and/or adult-use cannabis sales; headquarters and primary operational hubs located in states with established cultivation and retail infrastructure. Founding and corporate structure: - Founding year: established prior to the 2010s as a pioneer in vertically integrated cannabis operations in the U.S. - Headquarters: United States (headquarters locations in states where the company maintains primary corporate functions and strategic leadership). - Subsidiaries/affiliates: operates through a network of owned and operated dispensaries, cultivation facilities, processing labs, and distribution centers; maintains relationships with state regulators and license holders to support regulated commerce. Note: Trulieve emphasizes a vertically integrated, asset-light approach where feasible within state-by-state regulatory constraints, leveraging in-house cultivation, processing, and retail networks to optimize product quality, supply chain efficiency, and direct-to-consumer accessibility. The company maintains a broad portfolio of products and brands designed to address diverse consumer preferences and medical needs while pursuing ongoing expansion and regulatory advancement across the U.S. market.

Company News

MCPAPIChat
  • The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor.

  • Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?

  • Trulieve Makes History As First US Cannabis Stock On NYSE